Don Tracy, Associate Editor from Pharmaceutical Executive - Journalist Profile

	Profile	Contacts	Recent Articles on Subject
1	Don Tracy, Associate Editor Pharmaceutical Executive Pharma Executive Magazine. London & New Jersey PharmaceuticalsHealthcare		AstraZeneca Vice President, Head of Breast Cancer Franchise, Discusses Impact of Truqap Approval - 12 months ago Examining the Prevalence of Underinsurance in Children with Special Health Care Needs - 12 months ago Lilly Pens Open Letter Raising Concerns Regarding Use of Mounjaro for Cosmetic Weight Loss - 12 months ago Reviewing the Accuracy of AI Provided Health Information - 12 months ago The Transformative Potential of AI and Machine Learning in Biomedical Research and Healthcare - about 1 year ago Survey: 79% of Respondents Admit to Neglecting Health Needs During the Holiday Season - about 1 year ago Study Finds Association Between Neighborhood-Level Socioeconomic Status, Medication Nonadherence Among Heart Failure Patients - about 1 year ago Study Highlights Need for Pharma Industry to Address Stigmatization of Acne - about 1 year ago Report: Experimental HIV Vaccine Unlikely to be Effective in Preventing Acquisition - about 1 year ago Q&A With UCB's Camille Lee on the Bimzelx Navigate Patient Support System - about 1 year ago Q&A With UCB's Camille Lee on New Psoriasis Medication Approval - about 1 year ago Reviewing the FDA’s Regulatory Approach to Dietary Supplements - about 1 year ago Top Health Trends On the Horizon in 2024 - about 1 year ago Reviewing Consistency and Adequacy of Public vs. Commercial Health Insurance for American Children - about 1 year ago GSK Survey Discovers Extensive Misconceptions About Shingles - about 1 year ago Phase 3 Trial for GSK’s Blenrep Yields Positive Results in Relapsed or Refractory Multiple Myeloma - about 1 year ago Research Explores Adverse Outcomes From Energy Drink Intake Before, During Pregnancy - about 1 year ago Citing Ongoing Drug Shortages, Biden Administration Invokes Defense Production Act - about 1 year ago Phase 3 Clinical Trial for Dupixent Reports Significant Reduced COPD Exacerbations - about 1 year ago Investigating Industry Involvement in Modern Clinical Trials - about 1 year ago Phase 3 Study for AbbVie’s Ubrelvy Reports Promising Results - about 1 year ago The Importance of the Medical Affairs Function in Pharmaceutical Companies - about 1 year ago Analyzing Risks of Online Marketing for Teeth Whitening Products, Post-COVID - about 1 year ago Highlighting the Need for More Data to Achieve Global Health Equity - about 1 year ago The Promise and Concerns With AI in Pharma Research and Development - about 1 year ago Experts: It Will Take More Than Government Regulation of Pharmacy Benefit Managers to Lower Drug Costs - about 1 year ago Medical Debts in America: Collections, Aggressive Tactics, and Consequences - about 1 year ago Abbott’s Food as Medicine Program Reports Clinical Improvements in Patients with Diabetes - about 1 year ago Psychedelic Medicine: Developments, Evaluations, and Political Enthusiasm - about 1 year ago Janssen Sends Data for Phase III Children’s Pulmonary Tuberculosis Treatment to FDA and EMA - about 1 year ago Congress Launches Investigation into FDA Drug Shortage Response - about 1 year ago Medicare Price Negotiations: Will Big Pharma’s Opposition Push Back Future Drug Releases? - about 1 year ago ADHD Drug Shortages: Causes, Implications, and Solutions - about 1 year ago The Impact of GLP-1 Weight Loss Drugs on Patients, Healthcare Business - about 1 year ago Lexicon Pharmaceuticals’ Heart Failure Treatment Added to Express Scripts Formulary - about 1 year ago FDA Grants Fast Track Designation to Sellas Life Sciences’ SLS009 for Lymphoma - about 1 year ago Arrivent’s Furmonertinib Receives FDA Breakthrough Therapy Designation - about 1 year ago